Search for: "Tom Lamb" Results 361 - 380 of 1,044
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Mar 2007, 10:10 am
Popular Anemia Drugs Have Increased Risk Of Death, Blood Clots, Strokes, And Heart Attacks, Especially In Context Of Off-label Prescribing And Use (Posted by Tom Lamb at DrugInjuryWatch.com) On March 9, 2007 the FDA announced that Amgen Inc. and Johnson & Johnson (J&J) would add strong new warnings to their anemia drugs Procrit, Epogen, and Aranesp after several recent studies showed a higher risk of death and life-threatening side effects in some patients. [read post]
14 Jan 2011, 11:14 am by Tom Lamb
Steven Nissen To Express "concerns about the safety, efficacy and tolerability of dronedarone" (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE:  Multaq "safety warning" issued by European drug regulator MHRA on January 21, 2011:  "New information on possible risk of liver injury with dronedarone (Multaq)" Includes "Dear Doctor" letter sent by… [read post]
30 Sep 2010, 1:18 pm by Tom Lamb
Two More Fosamax Lawsuits Involving Jaw Injury Like Osteonecrosis Of The Jaw (ONJ) Will Go To Trial In Spring 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) _______________________________________________________________________________ UPDATE:  Merck Not at Fault in Fosamax Trial, Jurors Say  (New York Times, 11/19/10) ... [read post]
3 Mar 2009, 11:36 am
New Study Shows Older Diabetics Were More Likely To Develop Heart Failure Or Die When Using Avandia As Opposed To Actos (Posted by Tom Lamb at DrugInjuryWatch.com) In late November 2008 the medical journal Archives of Internal Medicine published an article about a study that found patients aged 65 and older who were taking Avandia (rosiglitazone) had a 15 percent higher rate of death and a 13 percent greater risk of heart failure when compared with similar patients taking… [read post]
10 Aug 2009, 11:43 am
Important Safety Information For Women Who Are Currently Using YAZ / Yasmin / Ocella, NuvaRing, Or Ortho Evra For Contraception Or Hormone Replacement Therapy (Posted by Tom Lamb at DrugInjuryWatch.com) For women who are using estrogen-progestin methods of birth control, here is some important information from WebMD's Birth Control Health Center about the symptoms of some serious, potentially  fatal  side effects: The following symptoms, called… [read post]
9 Nov 2007, 9:03 am
One Wonders Whether GSK Might Do A "Soft" Recall Of Its Embattled Diabetes Drug, As Was Done By BMS With Serzone And Tequin In Recent Years (Posted by Tom Lamb at DrugInjuryWatch.com) Avandia (rosiglitazone) is a prescription drug from GlaxoSmithKline (GSK) approved by the FDA in 1999 to treat Type 2 diabetes. [read post]
22 Aug 2008, 9:59 pm
FDA Rule Could Serve To Defeat Lawsuits Alleging Failure To Warn About Potentially Harmful Effects Of Prescription Drugs And Medical Devices (Posted by Tom Lamb at DrugInjuryWatch.com) Back in February 2008, in a post titled, "FDA Proposed Rule About Drug Label Warning Changes Will Lessen Agency's Power To Protect Us", I told you about a proposed rule that was issued in mid-January by the FDA. [read post]
10 Nov 2010, 5:55 am by Tom Lamb
Patients Have No Legal Claim Due To Federal Preemption Ruling (Posted by Tom Lamb at DrugInjuryWatch.com) As those who have been following the Sprint Fidelis litigation know by now, the thousands of product liability lawsuits that had been filed in connection with the defective lead wire recall by Medtronic did not go the way that injured plaintiffs had hoped. [read post]
10 Sep 2010, 1:27 pm by Tom Lamb
NEJM Editorial: There Should Be A Meridia Recall As The Risk Of Heart-Related Side Effects Is Greater Than Any Weight-Loss Benefit (Posted by Tom Lamb at DrugInjuryWatch.com)______________________________________________________________________________ UPDATE:  Abbott Pulls Meridia in U.S. [read post]
23 Feb 2010, 1:34 pm by Tom Lamb
Heart Risk Is Current Focus Due To GlaxoSmithKline Past Conduct; But Public Citizen Has Pointed The Liver Failure Case Reports Linked To Avandia, Also(Posted by Tom Lamb at DrugInjuryWatch.com) As some of you may recall, in October 2008 Public Citizen petitioned the FDA to ban the sale of the diabetes drug Avandia (rosiglitazone) in the U.S. because its risks, which include heart attack and heart failure in addition to liver toxicity, far outweigh its benefits and… [read post]
24 Feb 2009, 1:18 pm
Physicians Must Consider The Pros And Cons Of Surgical Removal Before Heart Device Shocks Unnecessarily Or Fails To Work When Patient Needed Shock (Posted by Tom Lamb at DrugInjuryWatch.com) On February 23, 2009 the medical journal HeartRhythm made available online an article by Robert G. [read post]
27 Aug 2007, 7:36 pm
[Tom] Dewey was a latecomer. [read post]
20 Dec 2014, 10:53 am by Tom Lamb
Advertisements As Well As Prescribing Information / Drug Label Seem To Downplay The Fact That There Is No Reversal Agent For Eliquis, Yet (Posted by Tom Lamb at DrugInjuryWatch.com) In print advertisements for their relatively new blood thinner medicine Eliquis, Bristol-Myers Squibb and Pfizer state in the Important Safety Information section ("August 2014" version): ELIQUIS can cause bleeding, which can be serious, and rarely may lead to death. [read post]
14 May 2014, 2:09 pm by Tom Lamb
For more information you can take a look at our previous articles: Benicar-Induced Enteropathy: Recently Found / New Possible Cause Of Villous Atrophy: Symptoms And Diagnosis Blood Pressure Drug Benicar Causes Serious Intestinal Side Effects Such As Chronic And Severe Diarrhea Months Or Years After Starting Drug Of course, we are continuing to monitor this drug safety issue concerning Benicar, Benicar HCT, Azor, and Tribenzor.… [read post]